204 related articles for article (PubMed ID: 17062769)
1. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.
Cust AE; Kaaks R; Friedenreich C; Bonnet F; Laville M; Lukanova A; Rinaldi S; Dossus L; Slimani N; Lundin E; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Mesrine S; Joulin V; Linseisen J; Rohrmann S; Pischon T; Boeing H; Trichopoulos D; Trichopoulou A; Benetou V; Palli D; Berrino F; Tumino R; Sacerdote C; Mattiello A; Quirós JR; Mendez MA; Sánchez MJ; Larrañaga N; Tormo MJ; Ardanaz E; Bueno-de-Mesquita HB; Peeters PH; van Gils CH; Khaw KT; Bingham S; Allen N; Key T; Jenab M; Riboli E
J Clin Endocrinol Metab; 2007 Jan; 92(1):255-63. PubMed ID: 17062769
[TBL] [Abstract][Full Text] [Related]
2. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.
Cust AE; Allen NE; Rinaldi S; Dossus L; Friedenreich C; Olsen A; Tjønneland A; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Linseisen J; Chang-Claude J; Boeing H; Schulz M; Benetou V; Trichopoulou A; Trichopoulos D; Palli D; Berrino F; Tumino R; Mattiello A; Vineis P; Quirós JR; Agudo A; Sánchez MJ; Larrañaga N; Navarro C; Ardanaz E; Bueno-de-Mesquita HB; Peeters PH; van Gils CH; Bingham S; Khaw KT; Key T; Slimani N; Riboli E; Kaaks R
Int J Cancer; 2007 Jun; 120(12):2656-64. PubMed ID: 17285578
[TBL] [Abstract][Full Text] [Related]
4. Case-control study of endogenous steroid hormones and endometrial cancer.
Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Cust AE; Kaaks R; Friedenreich C; Bonnet F; Laville M; Tjønneland A; Olsen A; Overvad K; Jakobsen MU; Chajès V; Clavel-Chapelon F; Boutron-Ruault MC; Linseisen J; Lukanova A; Boeing H; Pischon T; Trichopoulou A; Christina B; Trichopoulos D; Palli D; Berrino F; Panico S; Tumino R; Sacerdote C; Gram IT; Lund E; Quirós JR; Travier N; Martínez-García C; Larrañaga N; Chirlaque MD; Ardanaz E; Berglund G; Lundin E; Bueno-de-Mesquita HB; van Duijnhoven FJ; Peeters PH; Bingham S; Khaw KT; Allen N; Key T; Ferrari P; Rinaldi S; Slimani N; Riboli E
Endocr Relat Cancer; 2007 Sep; 14(3):755-67. PubMed ID: 17914105
[TBL] [Abstract][Full Text] [Related]
6. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Allen NE; Key TJ; Dossus L; Rinaldi S; Cust A; Lukanova A; Peeters PH; Onland-Moret NC; Lahmann PH; Berrino F; Panico S; Larrañaga N; Pera G; Tormo MJ; Sánchez MJ; Ramón Quirós J; Ardanaz E; Tjønneland A; Olsen A; Chang-Claude J; Linseisen J; Schulz M; Boeing H; Lundin E; Palli D; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Bingham S; Khaw KT; Bueno-de-Mesquita HB; Trichopoulou A; Trichopoulos D; Naska A; Tumino R; Riboli E; Kaaks R
Endocr Relat Cancer; 2008 Jun; 15(2):485-97. PubMed ID: 18509001
[TBL] [Abstract][Full Text] [Related]
7. Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis.
Dossus L; Lukanova A; Rinaldi S; Allen N; Cust AE; Becker S; Tjonneland A; Hansen L; Overvad K; Chabbert-Buffet N; Mesrine S; Clavel-Chapelon F; Teucher B; Chang-Claude J; Boeing H; Drogan D; Trichopoulou A; Benetou V; Bamia C; Palli D; Agnoli C; Galasso R; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; van Duijnhoven FJ; Peeters PH; Onland-Moret NC; Redondo ML; Travier N; Sanchez MJ; Altzibar JM; Chirlaque MD; Barricarte A; Lundin E; Khaw KT; Wareham N; Fedirko V; Romieu I; Romaguera D; Norat T; Riboli E; Kaaks R
Am J Epidemiol; 2013 Apr; 177(8):787-99. PubMed ID: 23492765
[TBL] [Abstract][Full Text] [Related]
8. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
[TBL] [Abstract][Full Text] [Related]
9. Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece.
Petridou E; Mantzoros C; Dessypris N; Koukoulomatis P; Addy C; Voulgaris Z; Chrousos G; Trichopoulos D
J Clin Endocrinol Metab; 2003 Mar; 88(3):993-7. PubMed ID: 12629074
[TBL] [Abstract][Full Text] [Related]
10. Adiposity and Endometrial Cancer Risk in Postmenopausal Women: A Sequential Causal Mediation Analysis.
Dashti SG; English DR; Simpson JA; Karahalios A; Moreno-Betancur M; Biessy C; Rinaldi S; Ferrari P; Tjønneland A; Halkjær J; Dahm CC; Vistisen HT; Menegaux F; Perduca V; Severi G; Aleksandrova K; Schulze MB; Masala G; Sieri S; Tumino R; Macciotta A; Panico S; Hiensch AE; May AM; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Colorado-Yohar S; Ardanaz E; Allen NE; Weiderpass E; Fortner RT; Christakoudi S; Tsilidis KK; Riboli E; Kaaks R; Gunter MJ; Viallon V; Dossus L
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):104-113. PubMed ID: 33008875
[TBL] [Abstract][Full Text] [Related]
11. Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables.
Jürimäe J; Jürimäe T
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E42-7. PubMed ID: 17341545
[TBL] [Abstract][Full Text] [Related]
12. Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Luhn P; Dallal CM; Weiss JM; Black A; Huang WY; Lacey JV; Hayes RB; Stanczyk FZ; Wentzensen N; Brinton LA
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1304-12. PubMed ID: 23696194
[TBL] [Abstract][Full Text] [Related]
13. Circulating adiponectin levels and risk of endometrial cancer: the prospective Nurses' Health Study.
Soliman PT; Cui X; Zhang Q; Hankinson SE; Lu KH
Am J Obstet Gynecol; 2011 Feb; 204(2):167.e1-5. PubMed ID: 21047616
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
Lukanova A; Lundin E; Micheli A; Arslan A; Ferrari P; Rinaldi S; Krogh V; Lenner P; Shore RE; Biessy C; Muti P; Riboli E; Koenig KL; Levitz M; Stattin P; Berrino F; Hallmans G; Kaaks R; Toniolo P; Zeleniuch-Jacquotte A
Int J Cancer; 2004 Jan; 108(3):425-32. PubMed ID: 14648710
[TBL] [Abstract][Full Text] [Related]
15. Plasma adiponectin concentrations and risk of incident breast cancer.
Tworoger SS; Eliassen AH; Kelesidis T; Colditz GA; Willett WC; Mantzoros CS; Hankinson SE
J Clin Endocrinol Metab; 2007 Apr; 92(4):1510-6. PubMed ID: 17213279
[TBL] [Abstract][Full Text] [Related]
16. Association between adiponectin, insulin resistance, and endometrial cancer.
Soliman PT; Wu D; Tortolero-Luna G; Schmeler KM; Slomovitz BM; Bray MS; Gershenson DM; Lu KH
Cancer; 2006 Jun; 106(11):2376-81. PubMed ID: 16639730
[TBL] [Abstract][Full Text] [Related]
17. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
[TBL] [Abstract][Full Text] [Related]
18. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study.
Dossus L; Rinaldi S; Becker S; Lukanova A; Tjonneland A; Olsen A; Stegger J; Overvad K; Chabbert-Buffet N; Jimenez-Corona A; Clavel-Chapelon F; Rohrmann S; Teucher B; Boeing H; Schütze M; Trichopoulou A; Benetou V; Lagiou P; Palli D; Berrino F; Panico S; Tumino R; Sacerdote C; Redondo ML; Travier N; Sanchez MJ; Altzibar JM; Chirlaque MD; Ardanaz E; Bueno-de-Mesquita HB; van Duijnhoven FJ; Onland-Moret NC; Peeters PH; Hallmans G; Lundin E; Khaw KT; Wareham N; Allen N; Key TJ; Slimani N; Hainaut P; Romaguera D; Norat T; Riboli E; Kaaks R
Endocr Relat Cancer; 2010 Dec; 17(4):1007-19. PubMed ID: 20843938
[TBL] [Abstract][Full Text] [Related]
19. Premenopausal Circulating Androgens and Risk of Endometrial Cancer: results of a Prospective Study.
Clendenen TV; Hertzmark K; Koenig KL; Lundin E; Rinaldi S; Johnson T; Krogh V; Hallmans G; Idahl A; Lukanova A; Zeleniuch-Jacquotte A
Horm Cancer; 2016 Jun; 7(3):178-87. PubMed ID: 26925952
[TBL] [Abstract][Full Text] [Related]
20. The relation of serum adiponectin and leptin levels to metabolic syndrome in women before and after the menopause.
Siemińska L; Wojciechowska C; Foltyn W; Kajdaniuk D; Kos-Kudła B; Marek B; Nasiek M; Nowak M; Strzelczyk J; Zemczak A
Endokrynol Pol; 2006; 57(1):15-22. PubMed ID: 16575758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
